387 related articles for article (PubMed ID: 28344341)
1. Functional variomics and network perturbation: connecting genotype to phenotype in cancer.
Yi S; Lin S; Li Y; Zhao W; Mills GB; Sahni N
Nat Rev Genet; 2017 Jul; 18(7):395-410. PubMed ID: 28344341
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Variomics and Multi-omics Network Biology for Precision Medicine.
Li MM; Awasthi S; Ghosh S; Bisht D; Coban Akdemir ZH; Sheynkman GM; Sahni N; Yi SS
Methods Mol Biol; 2023; 2660():357-372. PubMed ID: 37191809
[TBL] [Abstract][Full Text] [Related]
3. e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks.
Li Y; Burgman B; Khatri IS; Pentaparthi SR; Su Z; McGrail DJ; Li Y; Wu E; Eckhardt SG; Sahni N; Yi SS
Nucleic Acids Res; 2021 Jan; 49(1):e2. PubMed ID: 33211847
[TBL] [Abstract][Full Text] [Related]
4. Edgotype: a fundamental link between genotype and phenotype.
Sahni N; Yi S; Zhong Q; Jailkhani N; Charloteaux B; Cusick ME; Vidal M
Curr Opin Genet Dev; 2013 Dec; 23(6):649-57. PubMed ID: 24287335
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
6. Pathway networks generated from human disease phenome.
Cirincione AG; Clark KL; Kann MG
BMC Med Genomics; 2018 Sep; 11(Suppl 3):75. PubMed ID: 30255817
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology.
Li Y; Zhang Y; Li X; Yi S; Xu J
Trends Biochem Sci; 2019 Aug; 44(8):659-674. PubMed ID: 31047772
[TBL] [Abstract][Full Text] [Related]
8. Introduction: Cancer Gene Networks.
Clarke R
Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
[TBL] [Abstract][Full Text] [Related]
9. Network analysis and juvenile idiopathic arthritis (JIA): a new horizon for the understanding of disease pathogenesis and therapeutic target identification.
Donn R; De Leonibus C; Meyer S; Stevens A
Pediatr Rheumatol Online J; 2016 Jul; 14(1):40. PubMed ID: 27411317
[TBL] [Abstract][Full Text] [Related]
10. Genotype networks shed light on evolutionary constraints.
Wagner A
Trends Ecol Evol; 2011 Nov; 26(11):577-84. PubMed ID: 21840080
[TBL] [Abstract][Full Text] [Related]
11. Structural and Functional Characterization of a Caenorhabditis elegans Genetic Interaction Network within Pathways.
Boucher B; Lee AY; Hallett M; Jenna S
PLoS Comput Biol; 2016 Feb; 12(2):e1004738. PubMed ID: 26871911
[TBL] [Abstract][Full Text] [Related]
12. Cancer networks and beyond: interpreting mutations using the human interactome and protein structure.
Gulati S; Cheng TM; Bates PA
Semin Cancer Biol; 2013 Aug; 23(4):219-26. PubMed ID: 23680723
[TBL] [Abstract][Full Text] [Related]
13. Integration of genomic information with biological networks using Cytoscape.
Bauer-Mehren A
Methods Mol Biol; 2013; 1021():37-61. PubMed ID: 23715979
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations, expression and interaction networks in human cancers.
Wang X; Sun Q
Oncotarget; 2017 Jan; 8(1):624-643. PubMed ID: 27880943
[TBL] [Abstract][Full Text] [Related]
15. Belief propagation in genotype-phenotype networks.
Moharil J; May P; Gaile DP; Blair RH
Stat Appl Genet Mol Biol; 2016 Mar; 15(1):39-53. PubMed ID: 26910752
[TBL] [Abstract][Full Text] [Related]
16. Large-scale datasets uncovering cell signalling networks in cancer: context matters.
Sharma S; Petsalaki E
Curr Opin Genet Dev; 2019 Feb; 54():118-124. PubMed ID: 31200172
[TBL] [Abstract][Full Text] [Related]
17. Gene networks underlying convergent and pleiotropic phenotypes in a large and systematically-phenotyped cohort with heterogeneous developmental disorders.
Andrews T; Meader S; Vulto-van Silfhout A; Taylor A; Steinberg J; Hehir-Kwa J; Pfundt R; de Leeuw N; de Vries BB; Webber C
PLoS Genet; 2015 Mar; 11(3):e1005012. PubMed ID: 25781962
[TBL] [Abstract][Full Text] [Related]
18. Interpretation of genomic variants using a unified biological network approach.
Khurana E; Fu Y; Chen J; Gerstein M
PLoS Comput Biol; 2013; 9(3):e1002886. PubMed ID: 23505346
[TBL] [Abstract][Full Text] [Related]
19. Simplistic pathways or complex networks?
Jørgensen C; Linding R
Curr Opin Genet Dev; 2010 Feb; 20(1):15-22. PubMed ID: 20096559
[TBL] [Abstract][Full Text] [Related]
20. In silico perturbation of drug targets in pan-cancer analysis combining multiple networks and pathways.
Cava C; Castiglioni I
Gene; 2019 May; 698():100-106. PubMed ID: 30840853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
